Overview
Fmoc-Thr(Trt)-OH, available in a convenient 5 g package, is an essential standard amino acid used primarily in peptide synthesis. With its specific structure, this reagent is invaluable for researchers looking to create complex peptides with precision and reliability. The Fmoc (9-fluorenylmethoxycarbonyl) protecting group is highly efficient, making this product a must-have for labs focused on peptide chemistry and biochemistry.
Key Features
- High purity Fmoc-Thr(Trt)-OH for reliable synthesis
- Ideal for use in solid-phase peptide synthesis
- Trityl (Trt) protecting group enhances stability during synthesis
- Available in 5 g packages to suit your project needs
- Streamlined processing for efficient lab workflows
Specifications
| Product Name | Fmoc-Thr(Trt)-OH |
| Weight | 5 g |
| Category | Threonine (Thr) |
| Type | Unlabeled Standard Amino Acid |
| Usage | Reagent for peptide synthesis |
FAQ
What is Fmoc-Thr(Trt)-OH used for?
Fmoc-Thr(Trt)-OH is primarily used as a reagent in peptide synthesis. It allows for the incorporation of threonine into peptides, which is vital for various biochemical applications.
How do I store Fmoc-Thr(Trt)-OH?
Store Fmoc-Thr(Trt)-OH in a cool, dry place away from direct sunlight. Ensure the container is tightly sealed to prevent moisture and contamination.
Can Fmoc-Thr(Trt)-OH be used for solid-phase peptide synthesis?
Yes, Fmoc-Thr(Trt)-OH is specifically designed for use in solid-phase peptide synthesis, making it an excellent choice for assembling complex peptide structures.
To enhance your peptide creations, explore our range of Fmoc-Thr(t Bu)-OH and check out the Fmoc-D-Thr(tBu)-OH – 5 g for even more options. If you’re interested in related products, you might want to look into Humanin C8A, sHNA – 1 mg as well.
Elevate your peptide synthesis efforts with Fmoc-Thr(Trt)-OH, your go-to reagent for reliable results in your laboratory. Don’t miss out on this essential component for your research, order today!
Browse more in Threonine (Thr).




Reviews
There are no reviews yet.